1. Home
  2. MCB vs IMNM Comparison

MCB vs IMNM Comparison

Compare MCB & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCB
  • IMNM
  • Stock Information
  • Founded
  • MCB 1999
  • IMNM 2006
  • Country
  • MCB United States
  • IMNM United States
  • Employees
  • MCB N/A
  • IMNM N/A
  • Industry
  • MCB Major Banks
  • IMNM Medicinal Chemicals and Botanical Products
  • Sector
  • MCB Finance
  • IMNM Health Care
  • Exchange
  • MCB Nasdaq
  • IMNM Nasdaq
  • Market Cap
  • MCB 694.8M
  • IMNM 748.3M
  • IPO Year
  • MCB 2017
  • IMNM 2020
  • Fundamental
  • Price
  • MCB $72.78
  • IMNM $10.87
  • Analyst Decision
  • MCB Buy
  • IMNM Strong Buy
  • Analyst Count
  • MCB 3
  • IMNM 5
  • Target Price
  • MCB $79.67
  • IMNM $26.40
  • AVG Volume (30 Days)
  • MCB 126.5K
  • IMNM 1.2M
  • Earning Date
  • MCB 07-17-2025
  • IMNM 08-11-2025
  • Dividend Yield
  • MCB 0.82%
  • IMNM N/A
  • EPS Growth
  • MCB N/A
  • IMNM N/A
  • EPS
  • MCB 6.17
  • IMNM N/A
  • Revenue
  • MCB $274,307,000.00
  • IMNM $10,938,000.00
  • Revenue This Year
  • MCB $11.02
  • IMNM N/A
  • Revenue Next Year
  • MCB $12.86
  • IMNM $259.34
  • P/E Ratio
  • MCB $11.90
  • IMNM N/A
  • Revenue Growth
  • MCB 10.33
  • IMNM N/A
  • 52 Week Low
  • MCB $40.21
  • IMNM $5.15
  • 52 Week High
  • MCB $80.20
  • IMNM $16.81
  • Technical
  • Relative Strength Index (RSI)
  • MCB 50.28
  • IMNM 64.63
  • Support Level
  • MCB $72.95
  • IMNM $7.96
  • Resistance Level
  • MCB $80.20
  • IMNM $11.68
  • Average True Range (ATR)
  • MCB 2.32
  • IMNM 0.60
  • MACD
  • MCB -0.41
  • IMNM 0.22
  • Stochastic Oscillator
  • MCB 1.59
  • IMNM 78.23

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: